Aflibercept‑Jbvf Suppliers & Bulk Manufacturers

Available Forms: Intravitreal injection (liquid solution)

Available Strengths: 2 mg/0.05 mL per injection

Reference Brands: Eylea; Yesafili- biosimilar of Eylea

Category: Biosimilars

Aflibercept‑jbvf is available in Intravitreal injection (liquid solution) and strengths such as 2 mg/0.05 mL per injection. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Aflibercept‑jbvf is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Aflibercept‑jbvf can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Yesafili, a biosimilar of Eylea (aflibercept), is regulated in the EU and US, supported by dossiers demonstrating biosimilarity, safety, efficacy, and manufacturing quality according to GMP standards. In the US, FDA approval requires extensive comparability data, validation, and clinical validation. In the EU, CE marking certifies conformity under MDR standards. These biosimilars undergo validation, stability testing, and audits, with comprehensive documentation including safety profiles, clinical trial results, and manufacturing practices. For licensing procedures, approved dossiers, and latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to affordable, high-quality ophthalmic biosimilars for eye disease management worldwide.